Budget 2025: Govt's $164m plan for urgent, after-hours healthcare
New 24-hour urgent care services would be established in Auckland's Counties Manukau and Dunedin by the end of 2025, Tauranga in 2026, and Whangārei and Palmerston North in 2027.
New and extended daytime urgent care services were expected to roll out in Lower Hutt in 2025, Invercargill and Timaru in 2026.
Trials of rural and remote services were planned to take place in Twizel, Tākaka, Tūrangi, Te Kūiti, Coromandel and Great Barrier Island this year before being rolled out to more than 70 locations nationwide in the next two years.
Existing urgent and after-hours healthcare services would be maintained across the country.
Speaking at EastCare on Sunday, Prime Minister Christopher Luxon said the Government had promised to prioritise frontline services to deliver the care that families relIied on every day.
"It's about restoring faith in our healthcare system and making sure that patients come first.
"When a child's fever spikes in the middle of the night, parents have somewhere to go without delay. When an elderly person duffers from a fall they won't be left waiting in pain."
Brown said strengthening urgent and after-hours care was an "important part" of the Government's plan to ensure all New Zealanders had access to "timely, quality healthcare".
"This means 98% of New Zealanders will be able to receive in-person urgent care within one hour's drive of their homes," Brown said.
"Around 5000 New Zealanders visit urgent care clinics every day, but the availability of after-hours services has declined in recent years, and access remains variable across the country.
Brown said the expansion of community-based urgent care would help ease pressure on hospitals and keep emergency departments wait times down for those with the most serious conditions.
"We're taking action to ensure Kiwis can access the care they need, when and where they need it."
Associate Health Minister Matt Doocey said access to healthcare was one of the biggest concerns for people living in rural and remote communities.
"This investment will bring healthcare closer to home for more people."
He said rural New Zealanders deserved access to quality healthcare, and that the funding would reduce travel times, improve access, and take pressure off emergency departments.
"Geography shouldn't be a barrier to getting the healthcare you need."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
an hour ago
- NZ Herald
Gisborne-based Mātai Institute secures $563k for meth and sports brain research
'With at least one in three Kiwis affected by a neurological condition in their lifetime, the work of these researchers is crucial to advancing healthcare and improving people's quality of life,' said the Neurological Foundation's head of research and acting chief executive, Dr Sarah Schonberger. Dr Sarah Schonberger is the head of research and acting chief executive of the Neurological Foundation. Schonberger acknowledged times were tough for Kiwi researchers. 'The need for innovation in healthcare and disease prevention is increasing at exactly the same time that investment is shrinking,' she said. 'We are so grateful that our generous supporters are able to make a real difference by helping fund bold, brilliant New Zealand research like Maryam and Josh's, which holds so much promise for important breakthroughs.' Schonberger said the international experts who reviewed the funding applications described them as timely and relevant. 'The research being done at Mātai is genuinely world-class. Kiwis are fortunate that we have such a great hub of excellence in Gisborne,' she said. Holdsworth said the institute was 'incredibly proud' to see Tayebi and McGeown recognised in the funding round. 'A huge thank you to the Neurological Foundation and its supporters for backing world-class science here in Tairāwhiti. 'We're also deeply grateful to the Hugh Green Foundation and the Fred Lewis Foundation – long-standing pillars of support, who, among others, have helped us reach this point in these projects.' The Neurological Foundation is the biggest non-government funder of neurological research in the country. McGeown received a further $3956 to attend the International Brain Injury Association (IBIA) World Congress. Mātai research projects receiving funding MRI biomarkers of brain recovery and treatment response in methamphetamine addiction: A longitudinal study Dr Maryam Tayebi Methamphetamine (meth) addiction is a huge problem affecting people's lives across New Zealand, with no effective medicines available yet. This project is investigating how meth addiction affects the brain and how it might heal during recovery. Using advanced MRI brain scans, researchers will track changes in the brains of people receiving treatment. The goal is to find signs that show who is likely to stay drug-free and who might relapse. By understanding how the brain recovers, doctors can better support people with meth addiction. This research could lead to more personalised treatments, making a big difference in how meth addiction is managed and helping more people successfully overcome addiction. Brain health in collision sports: Linking early-life changes to long-term clinical outcomes using multimodal neuroimaging Dr Joshua McGeown Many athletes in collision sports suffer repeated head impacts, which may lead to brain damage and higher risk for neurodegenerative disease. This damage is often 'invisible' because there is no noticeable bruising or swelling, and standard medical imaging doesn't show abnormalities. This research project uses clinical data and advanced brain scans from active and retired athletes to track how head impacts affect the brain over time. In collaboration with the Former Athlete Brain Health Research programme in Australia, this fellowship aims to understand whether early brain changes persist, progress, or recover. By studying active and retired athletes, the aim is to identify early signs of brain damage and develop better ways to prevent and treat injuries.
NZ Herald
5 hours ago
- NZ Herald
Scientists create a new online calculator that reveals your heart's age and your risk of heart disease
New ways of assessing heart health The idea of using health data to assess your risk of developing heart disease is hardly new, of course. The Framingham Risk Score, which uses various health metrics to predict your 10-year likelihood of developing heart disease, has been around for decades. More recently, the American Heart Association developed the Predicting Risk of Cardiovascular Disease Events (Prevent) equations, which use new data about the health of tens of thousands of American adults, beginning at age 30, to predict heart disease risk. Khan was the lead author of the 2023 study that laid out the Prevent equations. But she's also a clinician and knew from talking to patients that 'it's really hard to understand what a 10% risk' of developing heart disease in the near future 'means for you'. And she's a researcher who's studied longevity among the Amish and was interested in the differences between biological and chronological age, and why people born in the same year can seem to age quite differently. Those interests converged when she began wondering if she could reinterpret the Prevent equations into a framework that would be more intuitive for most people, telling them, in effect, if their hearts are ageing too fast. The study found most Americans have hearts older than their chronological age, with men averaging seven years older. Photo / 123rf Most Americans' hearts are older than they are So, she and her colleagues used the Prevent data to figure out benchmarks for optimal heart health markers, such as blood pressure and blood sugar, among men and women at every age from 30 to 79. These would set the underpinnings of the heart-age test. (Most of the metrics used in the calculator are standard, but some are more specialised, such as an eGFR, which tests kidney function.) Then, since they were interested in the state of heart health in America, they checked the heart ages of more than 14,000 men and women enrolled in the Government's huge and ongoing National Health and Nutrition Examination Survey. Most of them turned out to have hearts older than their biological age. Men, on average, had heart ages about seven years older than their chronological age, while women's hearts were about four years older than their birth years. The gulfs between actual and biological heart ages were largest among people, especially men, with a high school education or less and those who identified as black or Hispanic. But even many people in their 30s had relatively old hearts. What to do about an ageing heart What does it mean if the calculator says your heart is older than you? 'First, it's important to have context,' Khan said. 'A year's difference from your chronological age is probably not meaningful. But if people's hearts are more than five years or 10 years away from their chronological age, it's worth paying attention to what's going on and what might be driving that.' Talk to your doctor if your heart age is at least five years older than your calendar age, she said. The calculator might be indicating you'd benefit from more vigilance. 'We know that half of people with high blood pressure aren't being treated,' she said, 'and most people who qualify for statin therapy aren't on it.' The interventions needn't all be medical. 'Lifestyle changes, especially exercise and diet, are also important,' she said. Even people whose heart ages equal or prove younger than their actual age can benefit from that knowledge, she said. 'One of the most challenging things is to maintain healthy ageing.' So, as the years pass or you enter health transitions, such as menopause, the calculator might be able to help you track how well your heart continues to age. The study suggests that if your heart age is over five years older, consult a doctor and consider lifestyle changes. What the calculator leaves out The heart-age calculator has limits, though. 'It's a way to communicate risk that will resonate with some people,' said Martha Gulati, the director of preventive cardiology and associate director of the Barbra Streisand Women's Heart Centre at Cedars-Sinai Health Sciences University in Los Angeles. But its equations don't include certain cardiovascular risk factors specific to women, she said, such as menopausal changes and pregnancy complications. They also don't include estimations of aerobic fitness or exercise habits, which can be key to heart health, said Ulrik Wisloff, the head of the cardiac exercise research group at the Norwegian University of Science and Technology in Trondheim, Norway, who's studied exercise and longevity for decades. 'I still find it puzzling why physical activity and peak oxygen uptake have yet to be incorporated into the original Framingham risk model, despite strong evidence' for their predictive power, he said. His group has developed its own free, online calculator, based on exercise and endurance, that estimates your fitness age in comparison with your chronological age. The key point about all of these biological-age calculators, whether they focus on fitness or organs, such as hearts, is that they can serve as a wake-up call, Gulati said. If the numbers indicate your heart might be ageing too rapidly, that's a message that you probably need to be paying some more attention to your health. 'I do think' the heart-age calculator 'is a bit gimmicky,' Gulati said. 'But if it helps to motivate a patient to make changes, I'm here for it.'
Otago Daily Times
13 hours ago
- Otago Daily Times
Ireland's wine label warning decision one NZ should follow
Health warnings are not required on New Zealand wine labels. Last week it was revealed that one of New Zealand's major wineries was putting cancer warning labels on wine bottles destined for Ireland, in order to be compliant in time for Ireland's new law that comes into force next year. This immediately prompts the question: if the people of Ireland will be warned about the cancer risk of alcohol consumption, why not New Zealanders? The decision by Ireland to mandate cancer warning labels is consistent with global health advice, including from the United States Surgeon-general. This reflects the strong evidence that alcohol is a cause of at least seven types of cancer including breast, bowel and oesophageal. New Zealanders have the right to know about the harms of alcohol, including the cancer risk. Despite this, the alcohol industry does not support warning labels on their products. But evidence shows that warning labels are an effective way to increase consumers' awareness and knowledge of alcohol-related harms. Previous research has found that only 18% of New Zealanders are able to name alcohol as a risk factor for cancer — despite alcohol being estimated to cause 6% of all cancer deaths in New Zealand. Warning labels on alcohol products could provide health benefits by prompting conversations with healthcare professionals. Let's imagine a 50-year-old woman who drinks regularly, perhaps a bottle of wine (about eight standard drinks a week). She sees this new warning label, which makes her stop and think. The next time she goes to see her GP, she mentions it. This could lead to many beneficial conversations. If her GP tells her that breast cancer represents 28% of all new cancer cases caused by alcohol in New Zealand, this may be the nudge she needs to go and have her mammogram, which she has been putting off. Or they could discuss things she can do to lower her cancer risk, including reducing her alcohol consumption. They might also talk about nutrition, physical activity and sun exposure. She decides to make some changes, as her first grandchild is on the way and she wants to stay healthy. Or her doctor could talk to her about alcohol's link to bowel cancer, which finally makes her raise the changes to her bowel habits she has been troubled by for over a year, but too embarrassed to ask about. These are hypothetical scenarios, but it is easy to imagine how something as simple as a warning label could have positive flow-on effects. Our scenario is consistent with research; a 2023 review found that alcohol warning labels are effective at prompting discussion and raising awareness of alcohol-related harms. Perhaps that's why 66% of New Zealanders already support a mandatory cancer warning label on alcohol? When talking about public health interventions for alcohol, we often hear industry pushback to this from a framing of "personal choice". But we think this is missing an important concept — the idea of making an informed choice. If you use a health service in New Zealand you are protected under a Code of Rights, where you have the "right to be fully informed" and then the "right to make an informed choice and give informed consent". This means you must be given appropriate and accurate information to help you make a choice. Tobacco labels must depict the health consequences of smoking to support people buying them to make an informed choice. Indeed, the first two criteria for making an informed choice relating to smoking are that 1) people should be aware of the health risks, and 2) the specific diseases caused by smoking. Key to "informed choice" is the provision of accurate information. The alcohol industry should not be allowed to block New Zealand consumers from being informed of the cancer risk of their products. We urge the New Zealand government to follow Ireland's pioneering lead and mandate cancer warning labels on alcohol products. This needs to occur alongside other evidence-based interventions that the World Health Organization recommends. This includes reducing the number of places that can sell alcohol, reducing trading hours, making it less affordable (by increasing excise tax) and restricting alcohol marketing. Cancer warning labels are only one of the actions needed to reduce the huge burden of alcohol-related harm in our communities. But they are a simple solution, straightforward to implement and a positive step in the right direction. By doing so, the government would be helping to create an environment that supports free and informed choice. — Newsroom • Dr Rose Crossin is a senior lecturer in the Department of Population Health, University of Otago (Christchurch); Emma Shields is in the advocacy and public affairs team at the Cancer Society of New Zealand.
